TO ALL ENLISTED: PLACENTA TREATMENT:
https://www.timesofisrael.com/study-shows-placenta-treatment-effective-against-radiation-sickness/
LEUKINE:
https://www.oncnursingnews.com/web-exclusives/fda-approves-sargramostim-for-hematopoeic-acute-radiation-syndrome
https://www.prnewswire.com/news-releases/partner-therapeutics-ptx-announces-us-fda-approval-of-leukine-sargramostim-for-the-treatment-of-acute-radiation-syndrome-300660612.html
MYELO001:
https://globenewswire.com/news-release/2018/09/25/1575501/0/en/FDA-Grants-Myelo-Therapeutics-Orphan-Drug-Designation-for-Myelo001-as-Treatment-for-Acute-Radiation-Syndrome.html
RYANODEX:
https://www.businesswire.com/news/home/20181127005093/en/Eagle-Pharmaceuticals-Announces-Positive-Results-Pre-clinical-Study
LEUKINE:
https://www.oncnursingnews.com/web-exclusives/fda-approves-sargramostim-for-hematopoeic-acute-radiation-syndrome
https://www.prnewswire.com/news-releases/partner-therapeutics-ptx-announces-us-fda-approval-of-leukine-sargramostim-for-the-treatment-of-acute-radiation-syndrome-300660612.html
MYELO001:
https://globenewswire.com/news-release/2018/09/25/1575501/0/en/FDA-Grants-Myelo-Therapeutics-Orphan-Drug-Designation-for-Myelo001-as-Treatment-for-Acute-Radiation-Syndrome.html
RYANODEX:
https://www.businesswire.com/news/home/20181127005093/en/Eagle-Pharmaceuticals-Announces-Positive-Results-Pre-clinical-Study
Comments
Post a Comment